Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis
CA 2329762 A1 · Owner: Verdier, Stephanie · Inventors: Vieillard-Baron, Corinne; Verdier, Stephanie; Meignant, Catherine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a pharmaceutical composition comprising a combination of at least two imidazole derivatives having reinforcing synergy against germs which cause infectious vulvovaginitis and vaginosis and selected from the group comprising metronidazole econazole, miconazole, clotrimazole, terconazole bifonazole, cloconazole, isoconazole, oxiconazole sulconazole, tioconazole and their salts preferably metronidazole combined with econazole. The composition is advantageously in galenic form of a hard or soft capsule having an solid hard or soft outer envelope containing gelatine enclosing an internal non-aqueous lipophilic liquid or semi-liquid phase wherein the imidazole derivatives …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.